Measurement and Training of Dual-Task of Gait in Persons With Multiple Sclerosis
MS
1 other identifier
interventional
80
1 country
2
Brief Summary
The purpose of this study is to determine the utility of a performance measure for the dual-task of gait and considering people with multiple sclerosis have both cognitive and motor problems, the secondary aim of this study is to determine the effectiveness of a gait-specific dual-tasking intervention for ambulatory individuals with multiple sclerosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable multiple-sclerosis
Started May 2018
Typical duration for not_applicable multiple-sclerosis
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2018
CompletedFirst Posted
Study publicly available on registry
May 24, 2018
CompletedStudy Start
First participant enrolled
May 31, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2020
CompletedSeptember 18, 2019
September 1, 2019
2 years
May 2, 2018
September 17, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Walking and Remembering Test
Measures dual-task cost of gait and a titrated forward digit span cognitive task, measured as a percentage.
Week 1, Week 2, Week 5, Week 8, Week 12
Secondary Outcomes (6)
Change in 2-Minute Walk Test
Week 1, Week 2, Week 5, Week 8, Week 12
Change in 12-Item Multiple Sclerosis Walking Scale
Week 1, Week 2, Week 5, Week 8, Week 12
Change in Fatigue Scale for Motor and Cognitive Functions
Week 1, Week 2, Week 5, Week 8, Week 12
Change in Gait Speed
Week 1, Week 2, Week 5, Week 8, Week 12
Change in Gait Cadence
Week 1, Week 2, Week 5, Week 8, Week 12
- +1 more secondary outcomes
Other Outcomes (2)
Changes in Visual Analog Scale for Fatigue
Week 1, Week 2, Week 5, Week 8, Week 12
Changes in Borg Rating of Perceived Exertion
Week 1, Week 2, Week 5, Week 8, Week 12
Study Arms (2)
Single-Task Gait
ACTIVE COMPARATORThe Single-Task Gait group will be provided with gait training without the Dual-Task cognitive tasks.
Dual-Task Gait
EXPERIMENTALThe Dual-Task Gait group will be provided with gait training AND secondary cognitive tasks during gait training.
Interventions
During the training sessions, you will participate in gait training with a physical therapist (PT). You will be asked to walk in 2-minute bouts and you will be provided with adequate rest breaks to help manage your fatigue levels. In addition to performing the gait training activities, you will be asked to perform thinking tasks at the same time. These pre-recorded questions or prompts will be provided to you through headphones and a portable music player. This is to help ensure that the PT is able to focus on giving you feedback about your walking ability and answers to the thinking tasks, and on your safety. At the end of each session, you will have walked for a total walking time of 20 minutes.
During the training sessions, you will participate in gait training with a physical therapist (PT). You will be asked to walk in 2-minute bouts and you will be provided with adequate rest breaks to help manage your fatigue levels. At the end of each session, you will have walked for a total walking time of 20 minutes.
Eligibility Criteria
You may qualify if:
- Ability walk independently with or without an assistive device
- Independent and community-dwelling
- No history or presence of other clinically significant musculoskeletal, cardiovascular, respiratory, or neurologic disease.
- Definite diagnosis of MS \[Expanded Disability Status Scale (EDSS) ≤6.5\]
- Relapse free for the past 30 days and not currently receiving or will receive any rehabilitation services during the study.
You may not qualify if:
- \- Participants experiencing a true relapse or exacerbation of their symptoms (\>24 hours duration in the absence infection or fever, or and ambient increase in body temperature) during the study will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Texas Woman's Universitylead
- TIRR Memorial Hermanncollaborator
- The University of Texas Health Science Center, Houstoncollaborator
Study Sites (2)
Texas Woman's University Institute of Health Sciences - Houston Center
Houston, Texas, 77030, United States
TIRR Memorial Hermann Adult and Pediatric Outpatient Rehabilitation at the Kirby Glen Center
Houston, Texas, 77030, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gregory Brusola, PT,DPT,MSCS
Texas Woman's University & TIRR Memorial Hermann
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2018
First Posted
May 24, 2018
Study Start
May 31, 2018
Primary Completion
May 31, 2020
Study Completion
May 31, 2020
Last Updated
September 18, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share